BioSpace News Archive

Citius Pharmaceuticals, Inc. today announced that the Company has received $2.4 million in non-dilutive capital.

QT Imaging Holdings, Inc. is pleased to announce the first commercial sale of a QTI Breast Acoustic CT ™ System to True Health Center for Functional Medicine.

BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell.

Sensible Medical , creator of the ReDS pulmonary congestion monitor, announces the publication of The ReDS-SAFE HF Trial; an international, multicenter, investigator initiated, randomized controlled trial, demonstrating a significant improvement in heart failure patients’ clinical outcomes by utilizing Remote Dielectric Sensing (ReDS)

AbTherx, Inc., a biotechnology company with innovative technologies that enable and accelerate antibody discovery, announced the appointment of Janine Schuurman, PhD, as a scientific advisor.

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that Cristin Hubbard has been named executive vice president and chief commercial officer.

MEDITECH is once again excited to feature its latest interoperability innovations in the HIMSS Interoperability Showcase.

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (“BioHarvest” or the “Company”), a biotechnology company pioneering its patented Botanical Synthesis technology process

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, March 28, 2024, at 4:30 p.m. Eastern Time to review 2023 fourth quarter and full year results.

TauRx Pharmaceuticals Ltd., a global leader in tau-based research in Alzheimer’s disease (AD), presented the 24-month data from its Phase 3 LUCIDITY trial of hydromethylthionine mesylate (HMTM) at the AD/PD™ 2024 Alzheimer’s & Parkinson’s Diseases Conference in Lisbon, Portugal.